论文部分内容阅读
目的:评估强化慢病管理门诊对冠心病患者的服药依从性,心血管事件再入院率,心功能评级的影响。方法:2012年1月~2013年12月在成都医学院第一附属医院心血管内科就诊的180例明确诊断冠心病的患者,分为强化管理组和一般管理组(对照组)。强化管理组每2周通过规范化慢病管理门诊方式随访,每3个月定期检测,一般管理组通过每月门诊或电话随访。观察两组患者服药依从性、心血管事件再入院率,心功能评级(NYHA评级)。结果:随访2年后发现,强化管理组阿斯匹林/氯吡格雷(74%vs.54%,P<0.01)、他汀类药物(69%vs.46%,P<0.01)、ACEI/ARB(76%vs.46%,P<0.01)和β受体阻滞剂(63%vs.42%,P<0.05)的服药率均优于一般管理组;因心血管事件再入院率也较低(26%vs.42%,P<0.05)。结论:加强对冠心病患者的规范化管理,有助于提高患者服药依从性,减少患者心血管事件再入院率。
OBJECTIVES: To assess the impact of intensive care management clinics on adherence to medication, cardiovascular readmission, and cardiac function in patients with coronary heart disease. Methods: From January 2012 to December 2013, 180 patients with definite diagnosis of coronary heart disease in Department of Cardiology, First Affiliated Hospital of Chengdu Medical College were divided into intensive management group and general management group (control group). The intensive management group followed up every two weeks through the standardized chronic disease management outpatient service and was regularly tested every three months. The general management group was followed up by monthly outpatient service or phone call. Compliance was observed in both groups, re-admission of cardiovascular events, and NYHA rating. RESULTS: After 2 years of follow-up, aspirin / clopidogrel (74% vs 54%, P <0.01), statins (69% vs 46% ARB (76% vs.46%, P <0.01) and β-blockers (63% vs.42%, P <0.05) were superior to the general management group; due to cardiovascular re-admission rate Lower (26% vs.42%, P <0.05). Conclusion: To strengthen the standardized management of patients with coronary heart disease, help to improve patient compliance and reduce cardiovascular re-admission rate of patients.